Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Obstructive sleep apnea (OSA) is independently associated with increased cardiovascular morbidity, and vitamin D deficiency is highly prevalent in OSA patients.
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Patients were classified into two cohorts based on their serum 25-hydroxyvitamin D (25 [OH] D) levels.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D deficiency and risk of heart failure in patients with obstructive sleep apnea: a cohort analysis
Study design awaiting verification · Frontiers in Nutrition · 2026
Original publication title
Vitamin D deficiency and risk of heart failure in patients with obstructive sleep apnea: a cohort analysis
Copyright © 2026 Chang, Weng, Hung, Ho, Lai, Wu and Chen.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Obstructive sleep apnea (OSA) is independently associated with increased cardiovascular morbidity, and vitamin D deficiency is highly prevalent in OSA patients. However, whether vitamin D deficiency is associated with an elevated risk of heart failure, specifically within the OSA population, remains unclear.
Source: BackgroundAbstract: What methods does the paper describe?
We conducted a retrospective cohort analysis using data from the TriNetX Global Collaborative Network (2010 to 2022) to investigate whether vitamin D deficiency, defined as a 25-hydroxyvitamin D concentration < 20 ng/mL, is associated with new-onset heart failure in adults diagnosed with OSA. Patients with sufficient vitamin D levels (≥30 ng/mL) served as controls. Propensity score matching (1:1) was performed to balance the baseline characteristics. The primary outcome was incident heart failure; secondary outcomes included all-cause mortality, secondary pulmonary hypertension, primary pulmonary hypertension, and pulmonary embolism at the 5-year follow-up.
Source: MethodsAbstract: Results
After propensity score matching, 36,497 patients were included in each cohort. Vitamin D deficiency was significantly associated with a higher risk of heart failure (HR 1.45; 95% CI 1.37 to 1.53; p < 0.001), all-cause mortality (HR 1.76; 95% CI 1.64 to 1.89; p < 0.001), secondary pulmonary hypertension (HR 1.25; 95% CI 1.13 to 1.38; p < 0.001), and pulmonary embolism (HR 1.31; 95% CI 1.17 to 1.47; p < 0.001). No significant association was observed with primary pulmonary hypertension (HR 1.22; 95% CI 0.84 to 1.79; p = 0.300).
Dose-response analysis revealed attenuated associations for vitamin D insufficiency (20 to 29.9 ng/mL). Subgroup analyses demonstrated a stronger association among obese patients (p for interaction = 0.028).
Source: ResultsAbstract: Conclusion
Among adults with OSA, vitamin D deficiency was linked to a markedly higher risk of developing heart failure as well as other unfavorable cardiopulmonary events, and this association demonstrated a clear dose: response pattern. These findings suggest that vitamin D status may represent an important factor in cardiovascular risk stratification in patients with OSA.
Source: ConclusionAuthors’ abstract
Background
Obstructive sleep apnea (OSA) is independently associated with increased cardiovascular morbidity, and vitamin D deficiency is highly prevalent in OSA patients. However, whether vitamin D deficiency is associated with an elevated risk of heart failure, specifically within the OSA population, remains unclear.
Methods
We conducted a retrospective cohort analysis using data from the TriNetX Global Collaborative Network (2010 to 2022) to investigate whether vitamin D deficiency, defined as a 25-hydroxyvitamin D concentration < 20 ng/mL, is associated with new-onset heart failure in adults diagnosed with OSA. Patients with sufficient vitamin D levels (≥30 ng/mL) served as controls. Propensity score matching (1:1) was performed to balance the baseline characteristics. The primary outcome was incident heart failure; secondary outcomes included all-cause mortality, secondary pulmonary hypertension, primary pulmonary hypertension, and pulmonary embolism at the 5-year follow-up.
Results
After propensity score matching, 36,497 patients were included in each cohort. Vitamin D deficiency was significantly associated with a higher risk of heart failure (HR 1.45; 95% CI 1.37 to 1.53; p < 0.001), all-cause mortality (HR 1.76; 95% CI 1.64 to 1.89; p < 0.001), secondary pulmonary hypertension (HR 1.25; 95% CI 1.13 to 1.38; p < 0.001), and pulmonary embolism (HR 1.31; 95% CI 1.17 to 1.47; p < 0.001). No significant association was observed with primary pulmonary hypertension (HR 1.22; 95% CI 0.84 to 1.79; p = 0.300).
Dose-response analysis revealed attenuated associations for vitamin D insufficiency (20 to 29.9 ng/mL). Subgroup analyses demonstrated a stronger association among obese patients (p for interaction = 0.028).
Conclusion
Among adults with OSA, vitamin D deficiency was linked to a markedly higher risk of developing heart failure as well as other unfavorable cardiopulmonary events, and this association demonstrated a clear dose: response pattern. These findings suggest that vitamin D status may represent an important factor in cardiovascular risk stratification in patients with OSA.
Publication and source details
Original title: Vitamin D deficiency and risk of heart failure in patients with obstructive sleep apnea: a cohort analysis
Ying-Jen Chang; Hsiu-Lan Weng; Kuo-Chuan Hung; Chun-Ning Ho; Yi-Chen Lai; Jheng-Yan Wu; I-Wen Chen
Frontiers in Nutrition · 2026
* Correspondence: I-Wen Chen, cheniwena60912@gmail.comThese authors have contributed equally to this work
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:59:25.353706+00:00
DOI: 10.3389/fnut.2026.1755607 · PMC12960163